Akari Therapeutics Plc logo

Akari Therapeutics Plc Share Price Today

(NASDAQ: AKTX)

Akari Therapeutics Plc share price is $0.89 & ₹77.40 as on 6 Mar 2025, 2.30 'hrs' IST

$0.89

-0.05

(-5.31%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Akari Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Akari Therapeutics Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Akari Therapeutics Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Akari Therapeutics Plc share price movements

  • Today's Low: $0.89
    Today's High: $0.98

    Day's Volatility :8.96%

  • 52 Weeks Low: $0.85
    52 Weeks High: $4.40

    52 Weeks Volatility :80.68%

Akari Therapeutics Plc (AKTX) Returns

PeriodAkari Therapeutics PlcIndex (Russel 2000)
3 Months
-25.98%
0.0%
6 Months
-71.06%
0.0%
1 Year
-57.27%
0.0%
3 Years
-96.36%
-11.6%

Akari Therapeutics Plc (AKTX) Key Statistics

in dollars & INR

Previous Close
$0.94
Open
$0.975
Today's High
$0.975
Today's Low
$0.8876
Market Capitalization
$30.3M
Today's Volume
$10.2K
52 Week High
$4.4
52 Week Low
$0.85
Revenue TTM
$0.0
EBITDA
$-18.1M
Earnings Per Share (EPS)
$-2.58
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1281.43%

How to invest in Akari Therapeutics Plc Stock (AKTX) from India?

It is very easy for Indian residents to invest directly in Akari Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Akari Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Akari Therapeutics Plc or AKTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Akari Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Akari Therapeutics Plc shares which would translate to 0.977 fractional shares of Akari Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Akari Therapeutics Plc, in just a few clicks!

Returns in Akari Therapeutics Plc (AKTX) for Indian investors in Rupees

The Akari Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Akari Therapeutics Plc investment value today

Current value as on today

₹45,417

Returns

₹54,583

(-54.58%)

Returns from Akari Therapeutics Plc Stock

₹59,545 (-59.55%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Akari Therapeutics Plc (AKTX)

-50%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Akari Therapeutics Plc Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Akari Therapeutics Plc

  • Palo Alto Investors, LLC

    0.55%

  • Omnia Family Wealth, LLC

    0.33%

  • HPM Partners LLC

    0.09%

  • Renaissance Technologies Corp

    0.09%

  • Cresset Asset Management, LLC

    0.07%

  • Accent Capital Management LLC

    0.04%

Analyst Recommendation on Akari Therapeutics Plc

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Akari Therapeutics Plc(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Akari Therapeutics Plc Stock (AKTX)

What analysts predicted

Upside of 8888.76%

Target:

$80.00

Current:

$0.89

Insights on Akari Therapeutics Plc Stock (Ticker Symbol: AKTX)

  • Price Movement

    In the last 7 days, AKTX stock has moved up by 2.2%
  • AKTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 120.7%
  • AKTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 144.2%

Akari Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Akari Therapeutics Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Akari Therapeutics Plc (AKTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Akari Therapeutics Plc logo
-21.01%
-71.06%
-57.27%
-96.36%
-97.23%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Akari Therapeutics Plc logo
NA
NA
0.0
0.0
-12.81
-1.73
NA
-0.04
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Akari Therapeutics Plc logo
Buy
$30.3M
-97.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Akari Therapeutics Plc

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.
Organization
Akari Therapeutics Plc
Employees
9
CEO
Dr. Samir Rashmikant Patel M.D.
Industry
Health Technology

Management People of Akari Therapeutics Plc

NameTitle
Dr. Samir Rashmikant Patel M.D.
President, CEO & Director
Dr. Torsten Hombeck Ph.D.
Chief Financial Officer
Dr. Miles Nunn
Chief Scientific Officer
Dr. Satyajit Mitra Ph.D.
Executive Director & Head of Oncology

Important FAQs about investing in AKTX Stock from India :

What is Akari Therapeutics Plc share price today?

Akari Therapeutics Plc share price today stands at $0.89, Open: $0.98 ; Previous Close: $0.94 ; High: $0.98 ; Low: $0.89 ; 52 Week High: $4.40 ; 52 Week Low: $0.85.

The stock opens at $0.98, after a previous close of $0.94. The stock reached a daily high of $0.98 and a low of $0.89, with a 52-week high of $4.40 and a 52-week low of $0.85.

Can Indians buy Akari Therapeutics Plc shares?

Yes, Indians can invest in the Akari Therapeutics Plc (AKTX) from India.

With INDmoney, you can buy Akari Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Akari Therapeutics Plc at zero transaction cost.

How can I buy Akari Therapeutics Plc shares from India?

It is very easy to buy Akari Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Akari Therapeutics Plc (AKTX) be purchased?

Yes, you can buy fractional shares of Akari Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Akari Therapeutics Plc stocks?

To start investing in Akari Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Akari Therapeutics Plc Stock (AKTX)?

Today’s highest price of Akari Therapeutics Plc (AKTX) is $0.98.

Today’s lowest price of Akari Therapeutics Plc (AKTX) is $0.89.

What is today's market capitalisation of Akari Therapeutics Plc?

Today's market capitalisation of Akari Therapeutics Plc AKTX is 30.3M

What is the 52 Week High and Low Range of Akari Therapeutics Plc Stock (AKTX)?

  • 52 Week High

    $4.40

  • 52 Week Low

    $0.85

What are the historical returns of Akari Therapeutics Plc (AKTX)?

  • 1 Month Returns

    -21.01%

  • 3 Months Returns

    -71.06%

  • 1 Year Returns

    -57.27%

  • 5 Years Returns

    -97.23%

Who is the Chief Executive Officer (CEO) of Akari Therapeutics Plc ?

Dr. Samir Rashmikant Patel M.D. is the current Chief Executive Officer (CEO) of Akari Therapeutics Plc.